These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24341950)

  • 41. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
    Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW
    J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical evaluation of a line probe assay kit for the identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis].
    Matsumoto T; Ogata H; Toyota E; Suzuki K; Saito T; Fujita A; Suetake T; Chikamatsu K; Mizuno K; Mitarai S
    Kekkaku; 2013 Mar; 88(3):291-6. PubMed ID: 23672169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimycobacterial and antitumor activities of palladium(II) complexes containing isonicotinamide (isn): X-ray structure of trans-[Pd(N3)2(isn)(2)].
    de Souza RA; Stevanato A; Treu-Filho O; Netto AV; Mauro AE; Castellano EE; Carlos IZ; Pavan FR; Leite CQ
    Eur J Med Chem; 2010 Nov; 45(11):4863-8. PubMed ID: 20724041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.
    Luo X; Pires D; Aínsa JA; Gracia B; Duarte N; Mulhovo S; Anes E; Ferreira MJ
    J Ethnopharmacol; 2013 Mar; 146(1):417-22. PubMed ID: 23337743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antituberculosis activity of novel 5-styryl-4-(hetero)aryl-pyrimidines via combination of the Pd-catalyzed Suzuki cross-coupling and S(N)(H) reactions.
    Kravchenko MA; Verbitskiy EV; Medvinskiy ID; Rusinov GL; Charushin VN
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3118-20. PubMed ID: 24856062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agents.
    Carmo AM; Silva FM; Machado PA; Fontes AP; Pavan FR; Leite CQ; Leite SR; Coimbra ES; Da Silva AD
    Biomed Pharmacother; 2011 Jun; 65(3):204-9. PubMed ID: 21602021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antimycobacterial activity of capreomycin.
    Lucchesi M
    Antibiot Chemother; 1970; 16():27-31. PubMed ID: 4108891
    [No Abstract]   [Full Text] [Related]  

  • 49. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
    Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
    Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of in-vitro and in-vivo activities of enoxacin and ofloxacin against the Mycobacterium tuberculosis].
    Xu G; Li H; Liu S
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):175-7, 192. PubMed ID: 8565090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and pharmacological evaluation of clubbed isopropylthiazole derived triazolothiadiazoles, triazolothiadiazines and mannich bases as potential antimicrobial and antitubercular agents.
    Suresh Kumar GV; Rajendra Prasad Y; Mallikarjuna BP; Chandrashekar SM
    Eur J Med Chem; 2010 Nov; 45(11):5120-9. PubMed ID: 20797808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effectiveness of the drugs of streptomycin group in experimental studies on albino mice infected with Mycobacterium tuberculosis resistant to these drugs].
    Kozulitsyna TI; Kozlova NV
    Probl Tuberk; 1976 Sep; (9):70-4. PubMed ID: 64981
    [No Abstract]   [Full Text] [Related]  

  • 53. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.
    Prammananan T; Arjratanakool W; Chaiprasert A; Tingtoy N; Leechawengwong M; Asawapokee N; Leelarasamee A; Dhiraputra C
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):216-9. PubMed ID: 15732744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and in vitro antitubercular activity of ferrocene-based hydrazones.
    Mahajan A; Kremer L; Louw S; Guérardel Y; Chibale K; Biot C
    Bioorg Med Chem Lett; 2011 May; 21(10):2866-8. PubMed ID: 21507641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
    Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
    Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pattern of capreomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H
    Kekkaku; 1968 May; 43(5):161-4. PubMed ID: 4971952
    [No Abstract]   [Full Text] [Related]  

  • 59. Capreomycin supergenerics for pulmonary tuberculosis treatment: preparation, in vitro, and in vivo characterization.
    Schoubben A; Blasi P; Marenzoni ML; Barberini L; Giovagnoli S; Cirotto C; Ricci M
    Eur J Pharm Biopharm; 2013 Apr; 83(3):388-95. PubMed ID: 23220041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The copper (II) ion as a carrier for the antibiotic capreomycin against Mycobacterium tuberculosis.
    Manning T; Mikula R; Lee H; Calvin A; Darrah J; Wylie G; Phillips D; Bythell BJ
    Bioorg Med Chem Lett; 2014 Feb; 24(3):976-82. PubMed ID: 24424129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.